CALABRESE, Cecilia
 Distribuzione geografica
Continente #
EU - Europa 7.151
NA - Nord America 4.103
AS - Asia 3.390
SA - Sud America 532
Continente sconosciuto - Info sul continente non disponibili 308
AF - Africa 39
Totale 15.523
Nazione #
RU - Federazione Russa 4.708
US - Stati Uniti d'America 4.022
SG - Singapore 1.090
IE - Irlanda 736
CN - Cina 585
VN - Vietnam 581
IT - Italia 532
HK - Hong Kong 479
BR - Brasile 444
UA - Ucraina 294
GB - Regno Unito 273
DE - Germania 260
KR - Corea 224
JP - Giappone 147
SE - Svezia 87
IN - India 85
FI - Finlandia 82
TR - Turchia 61
GR - Grecia 56
FR - Francia 40
BD - Bangladesh 33
AR - Argentina 30
CA - Canada 30
MX - Messico 20
BE - Belgio 16
AT - Austria 15
IQ - Iraq 15
CO - Colombia 14
EC - Ecuador 14
ID - Indonesia 14
SC - Seychelles 13
PH - Filippine 12
ZA - Sudafrica 11
NL - Olanda 10
PY - Paraguay 10
PK - Pakistan 9
PL - Polonia 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
MA - Marocco 6
EE - Estonia 5
HN - Honduras 5
KZ - Kazakistan 5
UY - Uruguay 5
AZ - Azerbaigian 4
CR - Costa Rica 4
GT - Guatemala 4
JM - Giamaica 4
JO - Giordania 4
KE - Kenya 4
LB - Libano 4
LT - Lituania 4
RO - Romania 4
VE - Venezuela 4
BO - Bolivia 3
ES - Italia 3
MY - Malesia 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AL - Albania 2
BG - Bulgaria 2
CH - Svizzera 2
DK - Danimarca 2
EU - Europa 2
IR - Iran 2
KG - Kirghizistan 2
NI - Nicaragua 2
PA - Panama 2
SA - Arabia Saudita 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
CM - Camerun 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
VC - Saint Vincent e Grenadine 1
Totale 15.217
Città #
Moscow 1.721
Dublin 737
Hong Kong 468
Jacksonville 459
Singapore 450
San Jose 445
Santa Clara 372
Chandler 318
Council Bluffs 286
Ashburn 225
Seoul 216
Ho Chi Minh City 176
Hanoi 156
Princeton 110
Bremen 109
Roxbury 97
Ann Arbor 88
Hefei 86
Beijing 63
Medford 62
Cambridge 60
Wilmington 60
Naples 56
Houston 48
Bengaluru 46
The Dalles 46
Da Nang 43
Dallas 43
Boardman 42
New York 39
Los Angeles 35
Mountain View 32
Munich 32
Woodbridge 31
Rome 30
São Paulo 30
Haiphong 28
Bari 25
Caserta 23
San Mateo 23
Milan 22
Nuremberg 22
Jinan 21
Atlanta 19
Des Moines 17
Brussels 16
Hải Dương 15
Phoenix 15
Chicago 14
Shenyang 14
Guangzhou 13
Rio de Janeiro 13
Tianjin 13
Fuzhou 12
Marano Di Napoli 12
Orem 12
Tokyo 12
Brooklyn 11
Kochi 11
Belo Horizonte 10
Biên Hòa 10
Brasília 10
Changsha 10
Frankfurt am Main 10
Memphis 10
Nanjing 10
Aversa 9
Helsinki 9
Montreal 9
Nanchang 9
Napoli 9
Quezon City 9
Quito 9
Thái Bình 9
Vienna 9
Hangzhou 8
Mumbai 8
Ningbo 8
San Francisco 8
Thái Nguyên 8
Bến Tre 7
Düsseldorf 7
Istanbul 7
Jakarta 7
Putian 7
Boston 6
Bắc Ninh 6
Curitiba 6
Cursi 6
Denver 6
Mexico City 6
Nha Trang 6
Ninh Bình 6
Salvador 6
Santiago 6
Tashkent 6
Villaricca 6
Zhengzhou 6
Amsterdam 5
Asunción 5
Totale 8.014
Nome #
Tollerabilità del GSH inalatorio in pazienti pediatrici e adulti con fibrosi cistica 215
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 194
Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19 171
Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction 167
A CASE OF A PULMONARY EPITHELIOID HEMANGIOENDOTHELIOMA TRANSFORMED INTO AN EPITHELIOID ANGIOSARCOMA 165
H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC. 159
T cell activation state in the induced sputum of asthmatics treated with budesonide 159
Application of proteomics and peptidomics to COPD. 158
Asma Bronchiale (recenti acquisizioni sperimentali e contributi personali) 158
Three Month Follow-Up of Patients With COVID-19 Pneumonia Complicated by Pulmonary Embolism 157
[Clinical use of recombinant IFN alfa-2b in the treatment of primary cancer of the lung (preliminary results)] 157
Exposure to Submicron Particles (PM1.0) from Diesel Exhaust and Pollen Allergens of Human Lung Epithelial Cells Induces Morphological Changes of Mitochondria Tonifilaments and Rough Endoplasmic Reticulum 156
EXPLORING THE ROLE OF KREBS VON DEN LUNGEN-6 (KL-6) IN SEVERE TO CRITICAL COVID-19: A SINGLE INSTITUTION EXPERIENCE 155
Arachidonic acid metabolism in inflammatory cells of patients with bronchial asthma 155
ANGIOGENESIS IN BRONCHIAL BIOPSIES OF SYMPTOMATIC SMOKERS WITH AND WITHOUT LUNG CANCER 154
Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages 153
Impact of long-term treatment with inhaled corticosteroids and bronchodilators on lung function in a patient with post-infectious bronchiolitis obliterans 153
Abdominal adiposity is an early marker of pulmonary function impairment: Findings from a Mediterranean Italian female cohort 149
A CASE OF DOUBLE AORTIC ARCH SUGGESTED BY THE ANALYSIS OF THE FLOW-VOLUME CURVE 148
ANGIOGENETIC AND APOPTOTIC PROCESS IN THE AIRWAYS OF SYMPTOMATIC SMOKERS WITH AND WITHOUT A CONTRALATERAL NON SMALL CELL LUNG CANCER 147
CORRELAZIONI TRA CELLULARITA' E MEDIATORI CHIMICI NEL LIQUIDO DI LAVAGGIO BRONCOALVEOLARE IN PAZIENTI CON ASMA BRONCHIALE ATOPICO 146
Basophil activation test for staphylococcus enterotoxins in severe asthmatic patients 145
Evolution of the Clinical Profile and Outcomes of Unvaccinated Patients Affected by Critical COVID-19 Pneumonia from the Pre-Vaccination to the Post-Vaccination Waves in Italy. 143
Lung mast cells are a source of secreted phospholipases A(2). 143
AGONISTI BETA2-ADRENERGICI 143
Ruolo dei fattori di crescita nella induzione della proliferazione fibroblastica nella patogenesi della fibrosi polmonare idiopatica 142
Obstructive sleep apnea and cardiovascular risks in the elderly population 141
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 141
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 140
BRONCHIAL VASCULARITY IN THE AIRWAYS OF CHRONIC BRONCHITIS AND COPD SMOKERS 140
Immunoflogosi nell’Asma Bronchiale 140
NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis 139
The serum metabolome of moderate and severe covid-19 patients reflects possible liver alterations involving carbon and nitrogen metabolism 139
Aerosol delivery through high-flow nasal therapy: Technical issues and clinical benefits 135
Asma e gravidanza 133
ASMA E MENOPAUSA 133
Association between exhaled nitric oxide and nasal polyposis in severe asthma 133
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 132
Correlation study of semi-quantitative CT emphysema score with the BODE index in COPD patients 131
A storm of stones in the lungs: an uncommon sequela of varicella pneumonia 130
IL POLMONE NELL'ARTRITE REUMATOIDE E NEL LUPUS ERITEMATOSO SISTEMICO 129
Evaluation of Allergic Diseases, Symptom Control, and Relation to Infections in a Group of Italian Elite Mountain Bikers. 128
ANTAGONISTI DEI LEUCOTRIENI E DI ALTRI MEDIATORI LIPIDICI 128
L'ASMA GRAVE: FENOTIPI CLINICI 127
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 125
MONITORAGGIO CLINICO E IMMUNOLOGICO DI UN GRUPPO DI PAZIENTI AFFETTI DA ASMA BRONCHIALE ATOPICO O ASMA BRONCHIALE E RINITE ALLERGICA IN TRATTAMENTO IPOSENSIBILIZZANTE SPECIFICO PER VIA SOTTOCUTANEA OD ORALE 124
Validation of Murray sputum purulence scale in the Italian Registry of Bronchiectasis (IRIDE) 123
Upregulation of miR-21 by Ras in vivo and its role in tumor growth 122
IFNY TRIGGERS APOPTOSIS IN VITRO M.T. ACTIVATED ALVEOLAR MACROPHAGES 122
NEUROPEPTIDE EXPRESSION IN THE AIRWAYS OF COPD PATIENTS AND SMOKERS WITH NORMAL LUNG FUNCTION. 121
Somatostatin-Dependent Regulation of Alveolar Macrophages Activation and Cytokine Production 121
Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis 121
Imbalance of circulating dendritic cell subsets in chronic obstructive pulmonary disease. 120
ACE Gene I/D Polymorphism and Acute Pulmonary Embolism in COVID19 Pneumonia: A Potential Predisposing Role 120
Role of monocyte/macrophage population in immune response 119
Dupilumab: A novel treatment for asthma 119
FIBROBLAST PROLIFERATION INDUCED BY GROWTH FACTORS IN DIOPATHIC PULMONARY FIBROSIS 117
Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis 117
New perspectives in asthma treatment 116
INFLUENZA DELL'INQUINAMENTO AMBIENTALE SULLA FUNZIONE RESPIRATORIA 116
VASCULAR REMODELLING IN BRONCHIAL MUCOSA OF SMOKERS WITH AND WITHOUT AIRWAY OBSTRUCTION 116
Impact of biologics on lung hyperinflation in patients with severe asthma 115
Pulmonary metastasis: very late relapse of testicular embryonal carcinoma 115
CARATTERISTICHE CLINICHE E MONITORAGGIO DEI PAZIENTI AFFETTI DA ASMA BRONCHIALE GRAVE DI DIFFICILE CONTROLLO 114
Effetti della stimolazione nasale con estratto di parietaria sui livelli di no esalato in pazienti con rinite allergica intermittente 114
Staphylococcus Aureus in chronic airway diseases: An overview 114
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy. 113
Psychological Factors Influencing Adherence to NIV in Neuromuscular Patients Dependent on Non Invasive Mechanical Ventilation: Preliminary Results 113
EVALUATION OF THE EFFICIENCY OF CORTICOSTEROID (BECLOMETIIASONE-DIPROPRIONATE) USE IN ATOPIC PATIENTS WITH MILD ASTHMA 113
IFNg triggers apoptosis in vitro M.T. activated alveolar macrophages 113
Inhaled glutathione tolerability and efficacy in patients with cystic fibrosis 112
Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD 112
S. aureus and IgE-mediated diseases: pilot or copilot? A narrative review 111
PHENOTYPIC FEATURES AND ACTIVATION OF ALVEOLAR MACROPHAGES IN ATOPIC ASTHMATIC PATIENTS 110
Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma 110
NMR metabolomic analysis of exhaled breath condensate of asthmatic patients at two different temperatures 110
Endoscopic central airway recanalization to enable first line pembrolizumab treatment in a PD-L1 strongly positive non-small cell lung cancer: a case report 110
Intranasal budesonide improves quality of life in patient with COPD and chronic nasal symptoms 109
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma 108
Recurrent respiratory infections caused by a double aortic arch: The diagnostic role of spirometry 107
CONFRONTO DEI FENOMENI DI ANGIOGENESI E DI PROLIFERAZIONE CELLULARE NELLE VIE AEREE DI FUMATORI SINTOMATICI CON E SENZA BPCO 107
Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma 107
FARMACI ATTIVI SUI MECCANISMI DELLA FLOGOSI 106
Lipid mediators from mast cells and basophils in allergic diseases 106
Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthma 106
Inhibition of Cytosolic Phospholipase A2 in Human Neutrophils by Oxatomide 103
Incidental late diagnosis of cystic fibrosis following AH1N1 influenza virus pneumonia: A case report 103
Diagnostica allergologica "in vivo" 102
Risultati preliminari sull'impiego della picotamide monoidrata in pazienti asmatici 102
METABOLISM OF LIPID MEDIATORS IN HUMAN EOSINOPHILS 101
TOSSE CRONICA E MALATTIA DA REFLUSSO GASTROESOFAGEO 101
The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro 101
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 100
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 99
Vascular remodelling in COPD airways 98
Short-term evaluation of dupilumab effects in patients with severe asthma and nasal polyposis 98
Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma 98
CYTOFLUORIMETRIC ANALYSIS OF CYTOKINE-PRODUCING LYMPHOCYTES IN BAL FROM TB PATIENTS 97
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 97
Alpha-1 antitripsyn deficiency and augmentation therapy in pregnancy: two case reports 96
Totale 12.701
Categoria #
all - tutte 55.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.150


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022741 0 0 0 5 213 46 15 32 23 117 54 236
2022/20231.428 135 9 28 107 216 113 24 59 682 14 17 24
2023/2024521 49 21 25 42 186 24 26 9 6 4 39 90
2024/20251.767 5 80 19 47 302 162 194 160 217 321 143 117
2025/20268.162 310 503 345 366 666 4.372 605 287 295 169 136 108
2026/20271.012 68 187 585 172 0 0 0 0 0 0 0 0
Totale 15.523